Product Categories
| Country: | China |
|---|---|
| Tel: | 0531-88723173 |
| Mobile: | 18596073690 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| C14H23N3O2S | 174656-58-7 | Details |
| C16H21ClN2S | 2760672-16-8 | Details |
| Details |
| N-nitrosolandinol | Details |
| Bromhexine complex impurity K | Details |
| Methyl 2-acetamido-4-acetoxybenzoate (INT1-J) | Details |
| 2-Acetylamino-6-methoxybenzoate methyl (INT2-S) | Details |
| Dimethyl 4-acetylamino-6-acetoxymethyl carthalate (INT2-K) | Details |
| [Des-Phe1,Des-Pro2]-BIVA | Details |
| Vonolazan fumarate M3-40 | Details |
| N-(2-(2-methoxy-4-(methylsulfonamide)-5-phenoxyphenyl)-2-oxyethyl)-N-methylformamide | Details |
| Ostarine | C19H14F3N3O3 | 841205-47-8 | Details |
| Ketotifen Impurity D | C19H19NO2S | 88456-70-6 | Details |
| Etofenamate EP Impurity C | C13H10F3N | 101-23-5 | Details |
| Impurity H | C23H27F2N3O3 | 2640158-02-5 | Details |
| N-Nitroso-L-hydroxyproline | C5H8N2O4 | 30310-80-6 | Details |
| Omadacycline Impurity 3 | C26H33N3O7 | 2272886-36-7 | Details |
| 3-Methyltetrahydroquinoline-8-sulfonate ethyl | Details |
| C12H21NO7 | 1103738-20-0 | Details |
| Vitamin B1 Impurity E | C12H16N4OS2 | 299-35-4 | Details |
| 1,7-Bis-(5-oxohexyl)-3-methylxanthine | C18H26N4O4 | 200556-62-3 | Details |
| Vitamin B1 Impurity F | C13H20Br2N4OS | 6309-04-2 | Details |
| Etofenamate EP Impurity E | C22H26F3NO4 | 2200281-00-9 | Details |
| C20H21N7O7.Ca | 67396-15-0 | Details |
| N-nitroso-ambroxol | Details |
| N-(2-(diethylamino)ethyl)-N-ethylnitrosamine (SM2-13) | Details |
| Afatinib maleate impurities HC1308-323 | Details |
| 2,2'-Bisnaltrexone | C40H44N2O8 | Details |
| Indobufen Impurity 19 | C10H13NO2 | 937671-41-5 | Details |
| Ibuprofen intermediate I impurity-4 | C13H17ClO | 89878-71-7 | Details |
| Nicardipine impurity (monomethyl ester analogue) | C15H16N2O4 | 85831-33-0 | Details |
| 3-Nitroso-1,3-thiazolidine | C3H6N2OS | 73870-33-4 | Details |
| 2-Amino-5-chloro-N-(2-(diethylamino)ethyl)-4-methoxybenzamide (Impurity S) | Details |
| Alteragliflozin finished impurities | Details |
| [Des-D-Phe1]-BIVA | Details |
| 1-piperidine-4-[1-(2-ethoxymethyl)-1H-benzimidazole-2-yl]-1,1-dimethylethyl ester | Details |
| Perospirone Impurity 5 | C8H11NO2 | Details |
| Etofenamate EP Impurity D | C32H26F6N2O5 | 64352-84-7 | Details |
| 2-(4-nitrosophenyl)butyric acid | C10H11NO3 | 1379292-20-2 | Details |
| Fmoc-Aph(L-Hor)-Aph(L-Hor)-OH | Details |
| Nicorandil Impurity 2 | C10H12N2O3 | 83440-03-3 | Details |
| Nicorandil Impurity 1 | C8H10N2O2 | 6265-74-3 | Details |
| Perospirone Impurity M | C23H30N4O2S | 190582-38-8 | Details |
| isobutyl carbamate | C5H11NO2 | 543-28-2 | Details |
| 4-chlorophenylhydroxylamine | C6H6ClNO | 823-86-9 | Details |
| Nicorandil Impurity 4 | C14H13N3O3 | 34104-46-6 | Details |
| Ilaprazole dithiodimer | C38H36N8O2S2 | 2285346-41-8 | Details |
| 2-Acetylamino-5-chloro-4. Methylbenzoate(INT3-P) | Details |
| 4-Acetylamino-6-acetoxymesophilic acid dicarboxylic acid (INT1-K) | Details |
| Vitamin B1 Impurity G | C14H20Cl2N4O2S | 1037-29-2 | Details |
| Vitamin B1 Impurity A | C12H16N4O4S2 | 2380-61-2 | Details |
| Ceftazidime EP Impurity G | C11H14N4O5S | 194241-83-3 | Details |
| (Z)-1,2-Bis(4-chlorophenyl)1-oxide | C12H8Cl2N2O | 21650-66-8 | Details |
| C18H26ClN3O3 | 1788104-74-4 | Details |
| Nitrosamine impurities-2 | C3H6N2O3 | Details |
| Diclofenac sodium Impurity 44 | Details |
| 5-Chloro-2-methoxy-4-dimethylaminobenzoate methyl (INT3-H) | Details |
| 2-(3-Aminophenyl)butyric acid | C10H13NO2 | 21762-24-3 | Details |
| C8H12O6 | 1103738-17-5 | Details |
| Ethyl 2-cyano-4,4-dimethoxybutanoate | C9H15NO4 | 773076-83-8 | Details |
| 6-bromo-2-hexanone | C6H11BrO | 10226-29-6 | Details |
| Nicorandil Impurity 3 | C10H14N2O3 | 149415-43-0 | Details |
| Vitamin B1 Impurity H | C14H20N4O3S2 | 89285-03-0 | Details |
| Finerenone SM3-03 | C6H8N2O | 52334-51-7 | Details |
| Impurity V | C13H17ClO | 80336-66-9 | Details |
| HS003-imp008 saxagliptin impurity | Details |
| Imp-Rux-23 Control | Details |
| Ibrutinib initiator I impurity A cyclic dimeric impurity derived impurity 3 | Details |
| 5-Chloro-N,N,4-trimethyl-1H-benzo[d]imidazo-2-amine | Details |
| Vitamin B1 Impurity B | C11H16Cl2N4OS | 49614-72-4 | Details |
| Tamsulosin hydrochloride SM2 impurity E control | C18H22O4 | 858583-36-5 | Details |
| (3R)-3-(4-chlorophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine | C16H19ClN2 | Details |
| 2-Formylbenzoic acid ethyl ester | C10H10O3 | 34046-43-0 | Details |
| Omadacycline Impurity 1 | C30H42N4O8 | 1075240-42-4 | Details |
| Omadacycline M+2 Impurity | 2272886-40-3 | Details |
| 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy-N-nitrosobenzamide (Impurity X) | Details |
| Methyl 4-Acetylamino-2-acetoxybenzoate (INT2-P) | Details |
| 2-Chloronitrosobenzene | C6H4ClNO | 932-33-2 | Details |
| Avanafil impurity AAN-IP-T | C22H24ClN7O3 | 330785-05-2 | Details |
| C15H17FO4 | 1369768-30-8 | Details |
| Avanafil impurity AAN-IP-R | Details |
| 5-Methoxy-2-(2H-1,2,3-triazol-2-yl)benzoic anhydride | Details |
| Methyl 4-acetylamino-2-acetoxybenzoate (INT2-G) | Details |
| Finerenone SM1-05 | C9H7NO2 | 21962-53-8 | Details |
| Vitamin B1 Impurity C | C12H17Cl3N4S | 7275-24-3 | Details |
| Levofloxacin Impurity J | C13H10FNO4 | 117620-84-5 | Details |
| Leoxiguat intermediate I control | C23H18FN9 | 370879-49-5 | Details |
| Dapagliflozin iMpurity F | Details |
| 4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-7-ethoxy-6-(2-hydroxy-5-oxopyrrolidin-1-yl)quinoline-3-carbonitrile | C28H24ClN5O4 | 1144516-15-3 | Details |
| Indobufen Impurity 17 | C20H19NO4 | 36691-07-3 | Details |
| ((6aR,9R,10aS)-10a-methoxy-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl)methanol | C17H22N2O2 | 35121-60-9 | Details |
| N-Nitroso Diphenhydramine | C16H18N2O2 | 55855-43-1 | Details |
| Ertugliflozin impurity | C21H23ClO7 | 1210344-55-0 | Details |
| Monoethyl phthalate | C10H10O4 | 2306-33-4 | Details |
| Avanafil impurity AAN-IP-Q | Details |
| 1,2-bis(5-(2-fluorophenyl)-1-(pyridine-3-ylsulfonyl)-1-H-pyrrole-3-yl)-2-hydroxyethyl-1-one | Details |
| Cetirizine hydrochloride impurity D (USP) | Details |
| (R)-5-chloro-4-methyl-2-(2-methylpyrrolidin-2-yl)-1H-benzo[d]imidazole | Details |
| 5-[1-(2-Chlorophenyl)-2-methoxy-2-oxoethyl]thieno[3,2-c]pyridinium Bromide | C16H13BrClNO2S | 1251736-86-3 | Details |
| C16H14O2 | 121917-04-2 | Details |
| Product Total： Product Page： | ||||
| 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 | ||||